Cybin Inc Sustainability Reports
Cybin Inc., operating commercially as Helus Pharma, is a clinical-stage biopharmaceutical company focused on developing psychedelic-based therapeutics and drug delivery systems to treat mental health disorders such as depression and anxiety.
Sector: Manufacturing
Country: Canada
Exchange: NYSE American
LEI: 549300NTYWN4CVYSCN32
FIGI: BBG00HZ0NJ24
5 reports from 2022 to 2026